Sparrow Pharmaceuticals, Inc. Employee Directory
Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees
Sparrow Pharmaceuticals, Inc. is a Boston-based company focused on targeted therapies for cardiometabolic diseases, aiming to improve outcomes for patients whose diabetes and related metabolic conditions are not adequately controlled by current options. Its lead candidate, clofutriben, is an oral inhibitor of HSD-1 taken once daily and developed for type 2 diabetes with elevated cortisol. HSD-1 inhibition is described as addressing an underlying driver of treatment resistance across metabolic dysfunction and is intended to complement standard antidiabetic therapies. The organization is led by a team of biotech executives, endocrinologists, and drug development veterans pursuing precision medicine in metabolic disease.